PTC Therapeutics (PTCT) Q3 Earnings and Revenues Top Estimates

PTC Therapeutics (PTCT) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of a loss of $1.19 per share. This compares to a loss of $1.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +116.81%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $1.07 per share when it actually produced a loss of $0.83, delivering a surprise of +22.43%.Over the last fo ...